PDS Biotechnology Corporation
PDS Biotechnology Corporation (PDSB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PDSB · as of Jun 9, 2026
Key Statistics
Explore PDS Biotechnology Corporation Data
pdsb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The PDSB analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing +800.00% upside from the current price of $1.00.
Competitors & Peers
pdsb competitorsPDSB
ANVS
ATNM
FGEN
INMB
KZRStock Performance
Full HistoryAbout PDS Biotechnology Corporation
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV1…
what is pds biotechnology corporation · pdsb stock overview · pds biotechnology corporation company profile · who is pds biotechnology corporation ceo · pdsb NASDAQ · pds biotechnology corporation headquarters · pds biotechnology corporation business segments
About Stock Overview & Key Data
PDS Biotechnology Corporation (PDSB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 30, 2015. As of the latest trading session, PDSB stock price is $1.00, with a market capitalization of $55.8M. The stock has returned -41.52% over the past 12 months and +29.90% year-to-date.
According to 7 Wall Street analysts, the consensus rating for PDS Biotechnology Corporation stock is Buy, with an average 12-month price target of $9.00. In fiscal year 2025, PDS Biotechnology Corporation reported revenue of — and net income of -$34.5M. For detailed data — including PDS Biotechnology Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PDS Biotechnology Corporation (PDSB) stock price is $1.00. The stock is traded on NASDAQ under the ticker symbol PDSB. The 52-week range is $0.51 – $1.92.